A variable dose phase 3, human bioassay of nortriptyline.
作者信息
Nodine J H, Siegler P E, Bodi T, Mapp Y, Dykyj R
出版信息
Am J Med Sci. 1965 Oct;250(4):443-7. doi: 10.1097/00000441-196510000-00011.
Abstract
摘要
相似文献
1
A variable dose phase 3, human bioassay of nortriptyline.
Am J Med Sci. 1965 Oct;250(4):443-7. doi: 10.1097/00000441-196510000-00011.
2
Current antidepressant therapy.
Psychosomatics. 1965 Sep-Oct;6(5):309-11. doi: 10.1016/s0033-3182(65)72243-3.
3
Verbal behaviour changes with depression treatment.
Can Psychiatr Assoc J. 1969 Oct;14(5):503-8. doi: 10.1177/070674376901400512.
4
[On the management of pain using antidepressive agents].
Klin Wochenschr. 1967 Sep 1;45(17):887-8. doi: 10.1007/BF01745688.
5
Therapy possibilities for therapy-resistant depressions.
Pharmakopsychiatr Neuropsychopharmakol. 1974 Jul;7(4):189-93. doi: 10.1055/s-0028-1094418.
6
[Clinical antidepressant drug therapy].
Tidsskr Nor Laegeforen. 1970 Mar 1;90(5):464-7.
7
Tricyclic antidepressants.
Br Med J. 1968 Apr 13;2(5597):102-4.
8
Antidepressants as a prophylaxis against depression in the obsessive compulsive person.
Psychosomatics. 1973 Jul-Aug;14(4):201-6. doi: 10.1016/S0033-3182(73)71332-3.
9
[Comparative clinical experiences with Protriptyline in depressive conditions of various origins].
Arzneimittelforschung. 1966 Jul;16(7):893-6.
10
The methylphenidate test for differentiating desipramine-responsive from nortriptyline-responsive depression.
Am J Psychiatry. 1983 Feb;140(2):212-4. doi: 10.1176/ajp.140.2.212.
引用本文的文献
1
Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review.
Eur Arch Psychiatry Clin Neurosci. 2005 Dec;255(6):387-400. doi: 10.1007/s00406-005-0579-5. Epub 2005 Apr 29.
2
Chlorpromazine in chronic schizophrenia: behavioral dose-response relationships.
Psychopharmacologia. 1970;18(3):260-70. doi: 10.1007/BF00412672.
Zotero 插件